What is STRATEOS?
STRATEOS is a pioneering force in the life sciences sector, specializing in the development of remote access laboratories and sophisticated lab automation software. The company's core mission is to accelerate scientific discovery by leveraging data, computation, automation, and high-throughput robotics. Its Strateos Cloud Lab Automation-as-a-Service Platform empowers scientists to design, execute, and analyze experiments with enhanced efficiency and reproducibility, ultimately driving new breakthroughs and faster scientific insights.
How much funding has STRATEOS raised?
STRATEOS has raised a total of $64.6M across 2 funding rounds:
Series A
$8.5M
Series B
$56.1M
Series A (2015): $8.5M with participation from MITS Fund, Wei Guo, Silicon Valley Bank, Holtzbrinck Digital, Paul Buchheit, Y Combinator, AME Cloud Ventures, DCVC, UpHonest Capital, and IA Ventures
Series B (2021): $56.1M led by Black Diamond Ventures, Eli Lilly, Lux Capital, DCVC Management, and Ally Bridge Group
Key Investors in STRATEOS
Black Diamond Ventures
Black Diamond Ventures is an investment firm with updates expected soon, indicating a potential focus on emerging technology or venture capital opportunities.
Eli Lilly
Eli Lilly and Company is a global biopharmaceutical firm dedicated to the discovery, development, and commercialization of prescription medicines across key therapeutic areas like oncology and immunology.
Lux Capital
Lux Capital is a venture capital firm based in New York that invests in early-stage and growth-stage companies at the intersection of science and technology, including AI, robotics, and biotechnology.
What's next for STRATEOS?
With the infusion of $64.6M in total capital, STRATEOS is strategically positioned for accelerated growth and innovation. This major enterprise-level funding, including the recent $56.1M strategic investment, will likely fuel further expansion of its cloud lab automation platform and enhance its robotic capabilities. The company's focus on data-driven discovery and automation suggests a trajectory aimed at transforming research methodologies across the life sciences, potentially leading to new partnerships and broader adoption of its advanced laboratory solutions.
See full STRATEOS company page
